Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated Thrombotic Microangiopathy in Children.

Frost EL, Ofori J, Williams KM, Kenney E, Spencer K, Obordo J, Pickett L, Westbrook A, Schoettler ML

Open source

DOI
10.1002/1545-5017.70170
Published
2026 May
Container
Pediatric blood & cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/1545-5017.70170,
  title = {Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated Thrombotic Microangiopathy in Children.},
  author = {Frost EL and Ofori J and Williams KM and Kenney E and Spencer K and Obordo J and Pickett L and Westbrook A and Schoettler ML},
  year = {2026},
  journal = {Pediatric blood \& cancer},
  doi = {10.1002/1545-5017.70170},
  url = {https://doi.org/10.1002/1545-5017.70170}
}

RIS

TY  - JOUR
TI  - Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated Thrombotic Microangiopathy in Children.
AU  - Frost EL
AU  - Ofori J
AU  - Williams KM
AU  - Kenney E
AU  - Spencer K
AU  - Obordo J
AU  - Pickett L
AU  - Westbrook A
AU  - Schoettler ML
PY  - 2026
JO  - Pediatric blood & cancer
DO  - 10.1002/1545-5017.70170
UR  - https://doi.org/10.1002/1545-5017.70170
ER  - 

APA

EL, F., J, O., KM, W., E, K., K, S., J, O., L, P., A, W., & ML, S. (2026). Validation of D-Dimer as a Prognostic Biomarker in Transplant-Associated Thrombotic Microangiopathy in Children.. Pediatric blood & cancer. https://doi.org/10.1002/1545-5017.70170

Source records